Product Information
RAMIPRIL 2.5 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0460 per EA under NDC 68180058910. Its NADAC has been published 76 times since Mar 12, 2025.
FDA first approved this application on Jun 9, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Ramipril market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180058910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077626FDA Approved
6/9/2008
TE Code
AB
On Market Since
6/10/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 2.5 MG CAPSULE has been published 76 times since Mar 12, 2025, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0460 per EA |
|---|---|
| All-time high | $0.0622 (Apr 16, 2025) |
| All-time low | $0.0460 (Aug 19, 2026) |
| 52-week high | $0.0585 |
| 52-week low | $0.0460 |
| Median price | $0.0571 |
| Average price | $0.0562 |
| Largest weekly change | -10.7% (Jun 17, 2026) |
| Weeks tracked | 76 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 2.5 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.0460 per EA (NDC 68180058910), effective Aug 19, 2026.
How has the price of RAMIPRIL 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 2.5 MG CAPSULE has declined 20.5%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 2.5 MG CAPSULE?
Since Mar 12, 2025, the NADAC for RAMIPRIL 2.5 MG CAPSULE has ranged from a low of $0.0460 (Aug 19, 2026) to a high of $0.0622 (Apr 16, 2025), with a median of $0.0571 per EA.
Are there cheaper alternatives to RAMIPRIL 2.5 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RAMIPRIL 2.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMIPRIL 2.5 MG CAPSULE?
RAMIPRIL 2.5 MG CAPSULE (NDC 68180058910) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.